ArticleInternational journal of biological sciences2025

EMC2 promotes breast cancer progression and enhances sensitivity to PDK1/AKT inhibition by deubiquitinating ENO1.

Shihan Xiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.